Landmark Study for GlaxoSmithKline (GSK)'s Cervical Cancer Vaccine Published in The Lancet
7/7/2009 8:59:34 AM
More...
|
Novartis Pharmaceuticals Corporation (NVS)'s Gleevec(R) Substantially Reduces Risk of Cancer Returning in Patients with Life-Threatening Gastrointestinal Stromal Tumors, Lancet Reports
3/19/2009 10:44:12 AM
More...
|
Lancet Publishes Two-Year Results of Abbott Laboratories (ABT)'s Fully Bioabsorbable Drug Eluting Stent
3/13/2009 10:48:23 AM
More...
|
Landmark Study Published in The Lancet Oncology Shows Celgene Corporation (CELG)'s Vidaza(R) Demonstrates Unprecedented Overall Survival in Intermediate-2 and High-Risk Myelodysplastic Syndromes, as Well as Acute Myeloid Leukaemia
2/18/2009 10:03:30 AM
More...
|
NeurogesX, Inc. Announces Publication of Phase 3 Data for QUTENZA(TM) (NGX-4010) in Postherpetic Neuralgia (PHN) by The Lancet Neurology
1/13/2009 8:33:17 AM
More...
|
Vanda Pharmaceuticals, Inc. (VNDA) Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet
12/2/2008 9:02:12 AM
More...
|
Phase IIb Data Published in The Lancet Show That BG-12, Lancet’s Novel Oral Compound, Significantly Reduced Brain Lesions in Patients with Multiple Sclerosis
10/24/2008 9:45:43 AM
More...
|
Breast Cancer Drug Not Tied to Cognitive Decline, Lancet
9/3/2008 7:44:39 AM
More...
|
PTC Therapeutics, Inc.'s PTC124 Shows Promising Activity in Cystic Fibrosis; Phase 2 Proof-of-Concept Data Published in the Lancet
8/21/2008 6:34:59 AM
More...
|
The Lancet Neurology Publishes Clinical Results of PBT2 in Alzheimer's Disease Patients
7/29/2008 3:58:53 PM
More...
|
|